Global Inactivated Vaccines Market Analysis: Size, Drivers, Trends, Opportunities, And Strategies
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Inactivated Vaccines Market from 2024 to 2033?
The inactivated vaccines market has grown steadily, from $5.95 billion in 2023 to $6.19 billion in 2024, reflecting a CAGR of 4.2%. This growth is attributed to efforts to eradicate polio, influenza vaccination programs, the emergence of infectious diseases, and regulatory approvals.
The inactivated vaccines market is expected to grow steadily, reaching $7.33 billion by 2028, at a CAGR of 4.3%. This growth is driven by pandemic preparedness, vaccine coverage expansion, biomanufacturing advancements, and health equity initiatives. Major trends include mRNA platforms, combination vaccines, thermostable vaccines, and digital vaccine passports.
Claim Your Free Sample of the Global Inactivated Vaccines Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp
The rise in infectious diseases is anticipated to boost the inactivated vaccine market. Infectious diseases are caused by pathogens such as bacteria, viruses, fungi, or parasites, which spread from person to person and cause various health complications. Inactivated vaccines employ non-living pathogens to stimulate immune response, helping prevent diseases like polio, hepatitis A, and influenza. The World Health Organization reported a 4.5% rise in tuberculosis cases globally, from 10.1 million to 10.6 million in 2021, with Southeast Asia reporting 45% of cases and Africa 23%. Thus, the rising prevalence of infectious diseases is driving the inactivated vaccine market.
1) By Type: Viral Vaccine, Bacterial Vaccine
2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
Companies in the inactivated vaccines market are introducing new vaccines to sustain their market position. In January 2022, GSK plc, a UK-based pharmaceutical company, launched Shingrix, an inactivated vaccine for shingles prevention. This non-live, recombinant subunit vaccine is administered in two doses and was initially approved for individuals 50 years and older. It has since been expanded to include those 18 years and older who are at higher risk due to immunodeficiency or immunosuppressive conditions.
Order Now for Fast Delivery of Your Inactivated Vaccines Market Report!
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
North America was the largest region in the aircraft transparencies market in 2023. The regions covered in the aircraft transparencies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Inactivated Vaccines Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the inactivated vaccines market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Inactivated Vaccines Market Include
1. Inactivated Vaccines Market Executive Summary
2. Inactivated Vaccines Market Segments
3. Inactivated Vaccines Market Size And Template Market Growth Rate
4. Key Inactivated Vaccines Market Trends
5. Major Inactivated Vaccines Market Drivers
……
25. Key Mergers And Acquisitions In The Inactivated Vaccines Market
26. Top Inactivated Vaccines Companies
27. Inactivated Vaccines Market Opportunities And Strategies
28. Inactivated Vaccines Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Cancer Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report
DTP Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report
Companion Animal Veterinary Vaccines Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
